PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.
Frequently asked questions
What sector does PharmaEssentia (6446) operate in?
PharmaEssentia belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is PharmaEssentia (6446) current stock price?
As of the latest data, PharmaEssentia stock price is NT$1,445.00, with a previous close of NT$1,440.00. PharmaEssentia gained NT$5.00 in the last trading session, representing a 0.35% increase.
What is PharmaEssentia (6446) current market capitalization?
PharmaEssentia market cap is approximately 596.95 billion.
What is PharmaEssentia (6446) Earnings Per Share (EPS)?
The trailing EPS is NT$14.36, and the forward EPS is NT$21.58.
What is PharmaEssentia (6446) Price-to-Earnings (P/E) ratio?
PharmaEssentia current P/E ratio is 100.63, with a forward P/E of 66.95.
What is PharmaEssentia (6446) EBITDA?
PharmaEssentia EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.46 billion.
Does PharmaEssentia (6446) pay dividends?
Yes. PharmaEssentia pays annual dividends with an annualized yield of 0.1% and an estimated annual payout of NT$1.49 per share.
When is the next ex-dividend date for PharmaEssentia (6446)?
The next ex-dividend date is scheduled for July 09, 2027.
How did PharmaEssentia (6446) perform in its most recent earnings report?
In the last report (March 31, 2026), PharmaEssentia posted an EPS surprise of 36.03% and a revenue surprise of -7.41%.
What is PharmaEssentia (6446) beta (volatility) score?
PharmaEssentia has a beta of 0.610, indicating lower volatility than the overall market.
